340B For All? Rx Discount Expansion Coming -- With Or Without Health Reform
Executive Summary
The pharmaceutical industry should prepare for an expansion of the 340B drug discount program in the U.S. - regardless of the outcome of the health care reform debate
You may also be interested in...
340B Expansion, Revisions Becoming Front-Burner Issues For Pharma
Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry
340B Expansion, Revisions Becoming Front-Burner Issues For Pharma
Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry
New Zealand's PHARMAC Gains $41 Million In Funding; Adds Sprycel And Humira For Reimbursement
PERTH, Australia - New Zealand's Pharmaceutical Management Agency's 2009/2010 budget saw a $41 million increase, bringing the total agency budget to $694 million, with $10 million of the new funds transferred from New Zealand District Health Board budgets